• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPARγ2基因中的Pro12Ala替换与受体活性降低、较低的体重指数及改善的胰岛素敏感性相关。

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

作者信息

Deeb S S, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J

机构信息

Department of Medicine, University of Washington, Seattle 98195, USA.

出版信息

Nat Genet. 1998 Nov;20(3):284-7. doi: 10.1038/3099.

DOI:10.1038/3099
PMID:9806549
Abstract

The peroxisome proliferator-activated receptor-gamma (PPARgamma) is a transcription factor that has a pivotal role in adipocyte differentiation and expression of adipocyte-specific genes. The PPARgamma1 and gamma2 isoforms result from alternative splicing and have ligand-dependent and -independent activation domains. PPARgamma2 has an additional 28 amino acids at its amino terminus that renders its ligand-independent activation domain 5-10-fold more effective than that of PPARgamma1. Insulin stimulates the ligand-independent activation of PPARgamma1 and gamma2 (ref. 5), however, obesity and nutritional factors only influence the expression of PPARgamma2 in human adipocytes. Here, we report that a relatively common Pro12Ala substitution in PPARgamma2 is associated with lower body mass index (BMI; P=0.027; 0.015) and improved insulin sensitivity among middle-aged and elderly Finns. A significant odds ratio (4.35, P=0.028) for the association of the Pro/Pro genotype with type 2 diabetes was observed among Japanese Americans. The PPARgamma2 Ala allele showed decreased binding affinity to the cognate promoter element and reduced ability to transactivate responsive promoters. These findings suggest that the PPARgamma2 Pro12Ala variant may contribute to the observed variability in BMI and insulin sensitivity in the general population.

摘要

过氧化物酶体增殖物激活受体γ(PPARγ)是一种转录因子,在脂肪细胞分化和脂肪细胞特异性基因的表达中起关键作用。PPARγ1和γ2亚型是由可变剪接产生的,具有配体依赖性和非依赖性激活域。PPARγ2在其氨基末端有额外的28个氨基酸,使其非配体依赖性激活域比PPARγ1的激活域有效5至10倍。胰岛素刺激PPARγ1和γ2的非配体依赖性激活(参考文献5),然而,肥胖和营养因素仅影响人脂肪细胞中PPARγ2的表达。在此,我们报告,在中年和老年芬兰人中,PPARγ2中相对常见的Pro12Ala替代与较低的体重指数(BMI;P = 0.027;0.015)和改善的胰岛素敏感性相关。在日裔美国人中观察到Pro/Pro基因型与2型糖尿病关联的显著优势比(4.35,P = 0.028)。PPARγ2 Ala等位基因显示与同源启动子元件的结合亲和力降低,以及反式激活反应性启动子的能力降低。这些发现表明,PPARγ2 Pro12Ala变体可能导致普通人群中观察到的BMI和胰岛素敏感性的变异性。

相似文献

1
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.PPARγ2基因中的Pro12Ala替换与受体活性降低、较低的体重指数及改善的胰岛素敏感性相关。
Nat Genet. 1998 Nov;20(3):284-7. doi: 10.1038/3099.
2
Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.过氧化物酶体增殖物激活受体γ2(Pro12Ala)和胰岛素受体底物1(Gly972Arg)常见多态性之间对胰岛素敏感性的相互作用。
J Mol Med (Berl). 2002 Jan;80(1):33-8. doi: 10.1007/s001090100282. Epub 2001 Sep 15.
3
The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.波兰人群中PPARγ2基因Pro12Ala多态性与2型糖尿病易感性
Diabetes Res Clin Pract. 2003 Nov;62(2):105-11. doi: 10.1016/s0168-8227(03)00164-5.
4
Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.过氧化物酶体增殖物激活受体γ2 Pro12Ala多态性对肥胖、血脂及非胰岛素依赖型糖尿病的影响
Int J Obes Relat Metab Disord. 2000 Feb;24(2):195-9. doi: 10.1038/sj.ijo.0801112.
5
The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.Pro12Ala PPARγ2基因错义突变与瑞典中年男性的肥胖及胰岛素抵抗相关。
Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):159-63. doi: 10.1002/dmrr.371.
6
[Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].过氧化物酶体增殖物激活受体γ2基因Pro12Ala变异与2型糖尿病的关联
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8.
7
A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.过氧化物酶体增殖物激活受体γ2启动子中的一个功能性变体与皮马印第安人的肥胖和2型糖尿病预测指标相关。
Diabetes. 2003 Jul;52(7):1864-71. doi: 10.2337/diabetes.52.7.1864.
8
Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.中国和日本高血压家族中PPARγ2 Pro12Ala多态性与代谢变量的基于同胞的关联研究:一项蓝宝石研究。斯坦福亚太高血压与胰岛素抵抗项目。
J Mol Med (Berl). 2001 Nov;79(11):656-64. doi: 10.1007/s001090100255.
9
The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.过氧化物酶体增殖物激活受体γ2(PPARγ2)基因Pro12Ala多态性可能与2型糖尿病的抗性有关。
Biochem Biophys Res Commun. 2000 Apr 29;271(1):212-6. doi: 10.1006/bbrc.2000.2605.
10
The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients.过氧化物酶体增殖物激活受体γ2基因多态性Pro12Ala与2型糖尿病患者后代更好的胰岛素敏感性相关。
Horm Metab Res. 2000 Oct;32(10):413-6. doi: 10.1055/s-2007-978663.

引用本文的文献

1
Mediterranean Diet Outcomes Across the Mother-Milk-Infant Triad: A Narrative Review.母婴三元组中的地中海饮食结局:一项叙述性综述
Nutrients. 2025 May 23;17(11):1760. doi: 10.3390/nu17111760.
2
An exploratory, open-label, parallel group, randomised controlled trial evaluating the effect of gene based nutritional intervention in type 2 diabetes: The protocol for NUDGE clinical trial.一项评估基于基因的营养干预对2型糖尿病影响的探索性、开放标签、平行组随机对照试验:NUDGE临床试验方案。
Contemp Clin Trials Commun. 2025 Mar 17;45:101470. doi: 10.1016/j.conctc.2025.101470. eCollection 2025 Jun.
3
Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study.
消化性溃疡疾病药物对消化性溃疡患者2型糖尿病风险的影响:一项基于人群的回顾性队列研究。
Ther Adv Endocrinol Metab. 2025 Mar 19;16:20420188251323945. doi: 10.1177/20420188251323945. eCollection 2025.
4
The impact of PPARγ and ApoE gene polymorphisms on susceptibility to diabetic kidney disease in type 2 diabetes mellitus: a meta-analysis.PPARγ 和 ApoE 基因多态性对 2 型糖尿病患者糖尿病肾病易感性的影响:一项荟萃分析。
BMC Nephrol. 2024 Nov 30;25(1):436. doi: 10.1186/s12882-024-03859-6.
5
The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.过氧化物酶体增殖物激活受体在免疫介导的肠道疾病中的多功能作用。
Cells. 2024 Oct 12;13(20):1688. doi: 10.3390/cells13201688.
6
Genetic variants in , , and as potential biomarkers for severe obesity and metabolic complications.、、和中的基因变异作为严重肥胖和代谢并发症的潜在生物标志物。
Front Genet. 2024 May 22;15:1363417. doi: 10.3389/fgene.2024.1363417. eCollection 2024.
7
Association of Polymorphic Variants of TCF7L2 and PPARG Genes with Metabolic Markers in Patients with Early Disorders of Carbohydrate Metabolism.TCF7L2 和 PPARG 基因多态性与糖代谢早期紊乱患者代谢标志物的关系。
Bull Exp Biol Med. 2024 Feb;176(4):481-485. doi: 10.1007/s10517-024-06051-w. Epub 2024 Mar 16.
8
Immunogenetic Aspects of Sarcopenic Obesity.肌少症性肥胖的免疫遗传学方面。
Genes (Basel). 2024 Feb 5;15(2):206. doi: 10.3390/genes15020206.
9
Evaluating the Impact of Omega-3 Fatty Acid (Soloways) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial.评估 PPARG 多态性成年人中ω-3 脂肪酸(Soloways)补充对脂谱的影响:一项随机、双盲、安慰剂对照试验。
Nutrients. 2023 Dec 27;16(1):97. doi: 10.3390/nu16010097.
10
Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms.2 型糖尿病成人的代谢生物标志物:PPAR-γ2 和 PPAR-β/δ 多态性的作用。
Biomolecules. 2023 Dec 14;13(12):1791. doi: 10.3390/biom13121791.